Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
08/2012
08/29/2012CN101766637B Composite for disintoxicating and sobering
08/29/2012CN101732413B Chinese medicinal composition for treating arthromyodynia and preparation method thereof
08/29/2012CN101709251B Bee milk costus and amomum wine
08/29/2012CN101616657B Whitening agent
08/29/2012CN101516390B Agent for preventing development of reflex sympathetic dystrophy after stroke
08/29/2012CN101491663B Traditional Chinese medicine composition for treating various cancer
08/29/2012CN101474388B Improved prescription of Xianchan tablet medicament and preparation method thereof
08/29/2012CN101401878B Chinese medicinal composition for beauty treatment and face nursing, and preparation method thereof
08/29/2012CN101336972B Qingpeng paste and detection method thereof
08/29/2012CN101336938B Use of probiotics in preparing composition for treating and preventing hand-foot-mouth disease
08/29/2012CN101190267B Medicinal composition for treating cervical vertebra disease
08/28/2012WO2013130049A1 Method for enhancing efficacy and selectivity of cancer cell killing by dna damaging agents
08/28/2012US8252764 Compositions and methods of use of targeting peptides against placenta and adipose tissues
08/28/2012US8252746 Anti-angiogenic agents and methods of their use
08/28/2012US8252588 Stem cells having increased sensitivity to SDF-1 and methods of generating and using same
08/28/2012US8252586 Neural cell populations from primate pluripotent stem cells
08/28/2012US8252585 Neural progenitor cell populations
08/28/2012US8252537 5' portion of an intestinal lactase-phlorizine hydrolase (LPH) gene; point mutations; solid phase synthesis; immunoassay; vectors; primers; host cells; antibodies; kits; gene therapy
08/28/2012US8252341 Isolation of growth and differentiating factors from colostrum
08/28/2012US8252340 Extract for treating thrombotic diseases
08/28/2012US8252280 MAPC generation of muscle
08/28/2012US8252279 Nutrient broth comprising no cell attachment factors for use in propagation of neuronal cell lines
08/28/2012CA2649619C Whey protein-containing granules and method of producing the same
08/28/2012CA2450470C Method for rapid screening of bacterial transformants and novel simian adenovirus proteins
08/28/2012CA2445578C Biological pacemaker comprising dominant-negative kir2.1aaa
08/28/2012CA2434317C Manual processing systems and methods for providing blood components conditioned for pathogen inactivation
08/28/2012CA2395589C Method for removing multimers of human serum albumin
08/28/2012CA2387805C Nucleic acids encoding endotheliases, endotheliases and uses thereof
08/23/2012WO2012112776A2 Robust and efficient differentiation of human pluripotent stem cells to multipotent vascular progenitors
08/23/2012WO2012112723A2 Thin shell graft for cartilage resurfacing
08/23/2012WO2012112576A1 Treatment of amyotrophic lateral sclerosis using umbilical derived cells
08/23/2012WO2012112458A2 Compositions and methods for increasing reprogramming efficiency
08/23/2012WO2012112438A2 Anti-microbial agents and compositions and methods of production and use thereof
08/23/2012WO2012112417A2 Tissue grafts modified with a cross-linking agent and method of making and using the same
08/23/2012WO2012112410A2 Micronized placental tissue compositions and methods for making and using the same
08/23/2012WO2012112079A1 IMPROVING CELLULAR IMMUNOTHERAPEUTIC VACCINES EFFICACY WITH GENE SUPPRESSION IN DENDRITIC CELLS AND T-LYMPHOCYTES USING SiRNA
08/23/2012WO2012111997A2 Cell therapy composition for preventing or treating immune disease comprising mesenchymal stem cells and immunoregulatory t-cells as active ingredient
08/23/2012WO2012110665A1 Aqueous ionic solution containing seawater and at least one compound that is originally immiscible with seawater
08/23/2012WO2012110017A1 Dietetic or pharmaceutical preparation containing tartary buckwheat
08/23/2012WO2012092458A3 Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof
08/23/2012WO2012087037A3 Novel bacteriophage and antibacterial composition comprising the same
08/23/2012WO2012074265A3 Composition for promoting the stability of stem cells
08/23/2012WO2012070014A3 Identification of novel cell surface markers for pancreatic progenitor cells and definite endodermal cells
08/23/2012WO2012064090A9 Chemical preparation method of skeletal muscle-derived multipotent cells and use thereof
08/23/2012WO2012026712A4 Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing stem cells treated with nod2 agonist or cultured product thereof
08/23/2012WO2011061561A3 Method of obtaining regenerative molecular matrices and regenerative molecular matrices thus obtained
08/23/2012US20120216304 Humanized animals via tissue engineering and uses thereof
08/23/2012US20120214737 Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by nrg-2
08/23/2012US20120214731 Compound ws 727713
08/23/2012US20120214206 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS
08/23/2012US20120213866 Method and system for modulating substances affecting bodily processes
08/23/2012US20120213859 Process for demineralization of bone matrix with preservation of natural growth factors
08/23/2012US20120213858 Anti-reflux infant nutrition
08/23/2012US20120213853 Compositions and improved soft tissue replacement methods
08/23/2012US20120213852 Compositions and improved soft tissue replacement methods
08/23/2012US20120213833 Prevotella histicola preparations and the treatment of autoimmune conditions
08/23/2012US20120213755 Semi-synthetic platelet gel and method for the preparation thereof
08/23/2012US20120213754 Method of Preconditioning of Cell Suspensions
08/23/2012US20120213753 Lactobacillus plantarum strains as hypocholesterolemic agents
08/23/2012US20120213752 Isolated stromal cells and methods of using the same
08/23/2012US20120213751 Novel stem cells, nucleotide sequences and proteins therefrom
08/23/2012US20120213750 Use of adipose tissue-derived stromal stem cells in treating fistula
08/23/2012US20120213749 Cardiac muscle regeneration using mesenchymal stem cells
08/23/2012US20120213748 Cardiomyocytes and methods of producing and purifying cardiomyocytes
08/23/2012US20120213747 Methods of reducing transplant rejection and cardiac allograft vasculopathy by implanting autologous stem cells
08/23/2012US20120213746 METHOD AND COMPOUNDS FOR GENERATION OF iPSCs
08/23/2012US20120213745 Serum-free media and their uses for chondrocyte expansion
08/23/2012US20120213744 Compositions and methods for modulating stem cells and uses thereof
08/23/2012US20120213743 Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
08/23/2012US20120213742 Virus growing in hypoxic cell or virus vector expressing gene therein
08/23/2012US20120213741 Commercial scale process for production of prrsv
08/23/2012US20120213739 Method to grow lawsonia intracellularis bacteria in persistently infected mccoy cells
08/23/2012US20120213737 Compositions and methods for therapeutic membrane repair
08/23/2012US20120213736 Parvovirus methods and compositions for killing neoplastic cells
08/23/2012US20120213731 Methods and compositions for treating autoimmune diseases
08/23/2012US20120213730 Alteration of cell membrane for new functions
08/23/2012US20120213708 Hydrogel encapsulated cells and anti-inflammatory drugs
08/23/2012US20120213699 Single chain fragment of monoclonal antibody 9b9 and uses thereof
08/23/2012US20120210547 Immunoneutral silk-fiber-based medical devices
08/23/2012DE102011011092A1 Gelierendes Kollagen und Mittel zu dessen Bereitstellung Gelling collagen and means for its provision
08/23/2012CA2827645A1 Enhanced therapeutic usage of a purine nucleoside phosphorylase or nucleoside hydrolase prodrug related applications
08/23/2012CA2827563A1 Aqueous ionic solution containing seawater and at least one compound that is originally immiscible with seawater
08/23/2012CA2827288A1 Methods and compositions of producing patient-specific multipotent neuronal stem cells
08/23/2012CA2826359A1 Tissue grafts modified with a cross-linking agent and methods of making and using the same
08/22/2012EP2489729A2 Apoptotic cell-mediated transfection of mammalian cells with interfering RNA
08/22/2012EP2489280A2 Synbiotic to improve gut microbiota
08/22/2012EP2488216A1 Use of extract of leeches as anti-bacterial agent
08/22/2012EP2488209A1 Method for treating chronic nerve tissue injury using a cell therapy strategy
08/22/2012EP2488188A1 Compositions and methods and uses related thereto
08/22/2012EP2488187A2 Assay for the prediction of therapeutic effectiveness of mesenchymal stromal cells, and methods of using same
08/22/2012EP2488178A1 Combinations of a pi3k inhibitor and a mek inhibitor
08/22/2012EP2488164A2 Release of agents from cells
08/22/2012EP2488044A1 Allergy treatment using acid treated aqueous whey protein extract
08/22/2012EP2094722B1 Use of polypetides against diseases caused by protozoans
08/22/2012EP1759683B9 Scalp and hair-care composition
08/22/2012CN1767839B Antiallergic composition
08/22/2012CN1622815B Immune stimulating substance including methane nutrition bacteria biomass
08/22/2012CN1441676B Method of treatment using ligand-immunogen conjugates
08/22/2012CN102648274A Agent for promoting differentiation of pluripotent stem cells into cardiac muscle cells which includes nitrovin
08/22/2012CN102647991A Antiviral agent and food/beverage composition
1 ... 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 ... 1259